相关实验视频

Updated: Sep 13, 2025

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

通过基于CAR的免疫疗法向癌症干细胞:生物学,证据和未来的方向

Kaveh Hadiloo^1,2, Parsa Mostanadi^2,3, Ali Asadzadeh^2,3

¹Department of Surgery, Velayat Clinical Research Development Unit, Qazvin University of Medical Sciences, Qazvin, Iran.

Cancer cell international

|July 29, 2025

概括

用化学抗原受体 (CAR) 疗法向癌症干细胞 (CSC) 显示出预防癌症复发的前景. 研究探索CSC特异性抗原,如CD133和GD2,以改善免疫治疗结果.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

癌症干细胞 (CSCs) 驱动瘤的开始,进展和治疗阻力,有助于癌症复发.
目前的免疫疗法,如CAR T细胞,可以有效,但可能无法消除CSC,导致潜在的复发.

研究的目的:

审查CSCs的生物学及其在癌症中的作用.
评估针对CSC的化学抗原受体 (CAR) 疗法在预防癌症复发方面的潜力.
探索CSC特异性抗原和在开发基于CAR的有效CSC向策略方面的挑战.

主要方法:

对针对CSCs的CAR疗法的临床前和临床研究的审查.
对CSC特异性抗原的分析,如CD133和GD2.
评估包括标记特异性和瘤微环境 (TME) 抑制在内的挑战.

主要成果:

针对CSC的CAR策略,使用CD133和GD2等抗体,在质母细胞瘤,乳腺癌和其他恶性瘤的临床前和临床模型中显示出有效性.
尽管取得了成功,但仍存在诸如识别特定的CSC标记物和克服TME中介抑制等挑战.

结论:

用CAR疗法准CSC是一种有前途的策略,可以预防癌症复发并改善长期患者的治疗结果.
未来的研究重点是双重准和人工智能驱动的标记物发现,可能会增强CSC消除和推进个性化癌症免疫治疗.

关键词:

癌症干细胞是癌症干细胞.基于细胞的治疗方法化学抗原受体的化学抗原受体免疫治疗是一种免疫疗法.有针对性的治疗.瘤启动的开始

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

相关概念视频

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...